表紙
市場調查報告書

局部藥物輸送市場:成長,趨勢,及預測(2019年∼2024年)

Topical Drug Delivery Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 567974
出版日期 內容資訊 英文 115 Pages
商品交期: 2-3個工作天內
價格
Back to Top
局部藥物輸送市場:成長,趨勢,及預測(2019年∼2024年) Topical Drug Delivery Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年09月01日內容資訊: 英文 115 Pages
簡介

本報告提供全球局部藥物輸送市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,各給藥途徑·產品·地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的假設
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 成長要素
  • 阻礙因素
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各給藥途徑
    • 真皮
    • 眼科
    • 鼻子
    • 陰道
    • 其他
  • 各產品
    • 處方
    • 設備
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲地區
    • 南美

第6章 競爭情形

  • 企業簡介
    • Bayer AG
    • Cipla
    • Crescita Therapeutics Inc.
    • Glaxosmithkline
    • 久光製藥株式會社
    • Johnson & Johnson (Janssen Global Services, LLC)
    • Medpharm
    • Nestle (Galderma)
    • Novartis AG
    • Valeant Pharmaceuticals

第7章 市場機會及未來趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 52999

Market Overview

The prevalence of skin infections, like eczema, psoriasis, etc. and minor ailments, like acne are increasing and having a big impact on the market globally. Psoriasis affect is observed in people of all ages, and in all countries. The reported global prevalence of psoriasis ranges between 0.09% and 11.4%, making psoriasis a serious global problem, indicated by the report of the World Health Organization in 2016. Around 7.5 million US people are getting affected according to the American Academy of Dermatology (AAD). Hence, these statistics show that skin diseases prevalence is increasing at a faster pace and is becoming a global burden, which is likely to positively impact the growth of the topical drug delivery market.

The other factor that drives the market includes the ease of drug delivery, approval of new drugs and technological advances and innovations.

Scope of the Report

As per the scope of the report, topical drug delivery is a medication that is applied to a particular place on, or in the body, topically. Common skin diseases that are treated preferably by topical drug delivery system include bacterial and fungal infections, inflammations, acne, psoriasis, hair and skin problems.

Key Market Trends

Dermal segment holds the major share in the Topical Drug Delivery Market

The topical drug delivery market is segmented based on the route of administration, product, and region. Based on the product, it is bifurcated into formulation and device. The formulation is sub-segmented into a solid, liquid, and semi-solid. Devices are further classified into inhaler and patch. Based on the route of administration, it is classified into dermal, ophthalmic, nasal, oral-topical, vaginal, and others.

There have been significant advantages in the topical and transdermal drug delivery systems, to target a particular site in the body. The administration of drugs through the skin is also performed to achieve controlled or prolonged drug delivery and this route can be explored as an alternative to the oral route. The ease of use may reduce overall healthcare treatment costs. The dermal segment of the market studied is expected to have a positive contribution to market growth, as it is widely used and has certain benefits.

North America is expected to dominate the Market

Based on the geographic region, the market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America has been accounted for the highest share in the market due to the presence of a large number of pharmaceutical companies and drug delivery technology providers. On the other hand, Asia Pacific is also likely to register a healthy growth rate in the forecast years. The increasing geriatric population and the rising disposable income are few of the factors, which are expected to accelerate the growth of the Asia Pacific market in the coming years.

Competitive Landscape

The major players in the market include - Bayer AG, Cipla, Crescita Therapeutics Inc., GlaxoSmithKline, Nestle (Galderma), Valeant Pharmaceuticals, Novartis, Med pharm, Johnson & Johnson (Janssen Global Services, LLC), and Hisamitsu Pharmaceuticals.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Ease of Drug Delivery
    • 4.2.2 Approval of New Drugs
    • 4.2.3 High Prevalence of Skin Diseases
    • 4.2.4 Technological Advances and Innovations
  • 4.3 Market Restraints
    • 4.3.1 Regulatory Scenario and Pricing Pressure
    • 4.3.2 High Frequency of Product Recalls
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Route of Administration
    • 5.1.1 Dermal
    • 5.1.2 Ophthalmic
    • 5.1.3 Nasal
    • 5.1.4 Oral Topical
    • 5.1.5 Vaginal
    • 5.1.6 Others
  • 5.2 By Product
    • 5.2.1 Formulation
      • 5.2.1.1 Solid
      • 5.2.1.2 Semi-Solid
      • 5.2.1.2.1 Cream & Lotion
      • 5.2.1.2.2 Ointment
      • 5.2.1.2.3 Gel
      • 5.2.1.3 Liquid
      • 5.2.1.3.1 Solution
      • 5.2.1.3.2 Suspension
    • 5.2.2 Device
      • 5.2.2.1 Inhaler
      • 5.2.2.2 Patch
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 US
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 UK
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Bayer AG
    • 6.1.2 Cipla
    • 6.1.3 Crescita Therapeutics Inc.
    • 6.1.4 Glaxosmithkline
    • 6.1.5 Hisamitsu Pharmaceuticals
    • 6.1.6 Johnson & Johnson (Janssen Global Services, LLC)
    • 6.1.7 Medpharm
    • 6.1.8 Nestle (Galderma)
    • 6.1.9 Novartis AG
    • 6.1.10 Valeant Pharmaceuticals

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top